Found 381 results
Journal Article
Barer ML. Case mix adjustment in hospital cost analysis: information theory revisited. Journal of health economicsJ.Health Econ.. 1982;1(1):53-80.
Morgan SG, McMahon M, Mitton C. Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.
Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health affairs (Project Hope)Health.Aff.(Millwood). 2006;25(2):337-347.
Sutherland JM, Walker J. Challenges of rehabilitation case mix measurement in Ontario hospitals. Health policy (Amsterdam, Netherlands)Health Policy. 2008;85(3):336-348.
Menec VH, Roos NP, Black CD, Bogdanovic B. Characteristics of patients with a regular source of care. Canadian journal of public health.Revue canadienne de sante publiqueCan.J.Public Health. 2001;92(4):299-303.
Brehaut JC, Miller A, Raina P, McGrail KM. Childhood behavior disorders and injuries among children and youth: a population-based study. PediatricsPediatrics. 2003;111(2):262-269.
Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Canadian journal of psychiatry.Revue canadienne de psychiatrieCan.J.Psychiatry. 2004;49(11):761-768.
Hanley GE, Morgan SG. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social science & medicine (1982)Soc.Sci.Med.. 2009;68(5):919-924.
Hanley G, Morgan SG. Chronic Catastrophes: Exploring the Concentration & Sustained Nature of Ambulatory Rx Drug Expenditures in the Population of BC. Social Science and Medicine. 2009.
Lander B, Hanley GE, Atkinson-Grosjean J. Clinician-scientists in Canada: barriers to career entry and progress. PloS onePLoS One. 2010;5(10):e13168.
Wong ST, Seago JA, Keane D, Grumbach K. College students' perceptions of their experiences: what do minority students think? The Journal of nursing educationJ.Nurs.Educ.. 2008;47(4):190-195.
McMahon M, Morgan SG, Mitton C. The Common Drug Review: a NICE start for Canada? Health policy (Amsterdam, Netherlands)Health Policy. 2006;77(3):339-351.
Watson D, Finlayson G, Jacobs P. Comparing apples to apples: the relative financial performance of Manitoba's acute care hospitals. Healthcare management forum / Canadian College of Health Service Executives = Forum gestion des soins de sante / College canadien des directeurs de services de santeHealthc.Manage.Forum. 2002;Suppl:39-46.
Morgan SG, Hanley G, Greyson D. Comparing tiered formularies and reference pricing policies: A systematic review. Open Medicine. 2009;3(3).
Reid R, Evans RG, Barer ML, Sheps S, Kerluke K, McGrail KM, et al. Conspicuous consumption: characterizing high users of physician services in one Canadian province. Journal of health services research & policyJ.Health Serv.Res.Policy. 2003;8(4):215-224.
Evans RG, Stoddart GL. Consuming research, producing policy? American Journal of Public HealthAm.J.Public Health. 2003;93(3):371-379.
Mustard CA, Mayer T, Black CD, Postl B. Continuity of pediatric ambulatory care in a universally insured population. PediatricsPediatrics. 1996;98(6 Pt 1):1028-1034.
Evans RG, Lomas J, Barer ML, Labelle RJ, Fooks C, Stoddart GL, et al. Controlling health expenditures--the Canadian reality. The New England journal of medicineN.Engl.J.Med.. 1989;320(9):571-577.
Barer ML. Controlling medical care costs in Canada. JAMA : the journal of the American Medical AssociationJAMA. 1991;265(18):2393-2394.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Kratzer J, McGrail KM, Strumpf E, Law M. Cost-Control Mechanisms in Canadian Private Drug Plans. Healthcare Policy. 2013;9(1):35-43.
Morgan SG, Kennedy J. Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Law M, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of internal medicine. 2009;169(21):1969.
Law M, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of Internal MedicineArch.Intern.Med.. 2009;169(21):1969-1974.
Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB. Creating a population-based linked health database: a new resource for health services research. Canadian journal of public health.Revue canadienne de sante publiqueCan.J.Public Health. 1998;89(4):270-273.